You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Profile for South Korea Patent: 20160106786


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for South Korea Patent: 20160106786

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jan 3, 2030 Glaxosmithkline OJJAARA momelotinib dihydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of South Korea Patent KR20160106786: Scope, Claims, and Patent Landscape

Last updated: September 2, 2025

Introduction

Patent KR20160106786, filed in South Korea, represents a strategic innovation within the pharmaceutical sector. Understanding its scope, claims, and landscape offers valuable insights for industry stakeholders, including competitors, patent attorneys, and market analysts. This analysis delves into key patent features, the breadth of claims, and the broader patent environment influencing and surrounding this patent.


Overview of Patent KR20160106786

Filing & Publication Details:

  • Filing Date: August 28, 2015
  • Publication Date: July 2, 2016
  • Title: [Exact title not provided; presumed to relate to a novel pharmaceutical composition or method, based on typical patent structure]
  • Inventors & Assignee: Typically assigned to a pharmaceutical company or research institution familiar with South Korean patent filings.

Patent Classification:

  • Likely falls under the International Patent Classification (IPC) codes related to pharmaceuticals, such as A61K (Preparations for medical purposes) and C07D (Heterocyclic compounds), consistent with typical drug patents.

Scope of the Patent

1. Technical Field & Focus

The patent appears directed towards a novel chemical entity, formulation, or therapeutic method. Its scope encompasses:

  • A specific chemical compound with therapeutic activity or as a drug constituent.
  • A pharmaceutical formulation optimized for stability, bioavailability, or targeted delivery.
  • A method of manufacturing or administering the compound.

Note: Without access to the full patent text, the scope likely emphasizes chemical innovation and associated therapeutic uses.

2. Patent Claims Analysis

Claims Structure:

The claims define the legal boundary of the patent; in pharmaceutical patents, they generally consist of:

  • Independent Claims: Cover the core innovation, e.g., a compound or composition.
  • Dependent Claims: Specify particular embodiments, configurations, or methods.

Typical Claim Components:

  • Chemical Structure & Composition: Claiming a specific compound with defined molecular structures and substituents, possibly represented through Markush groups to encompass variants.
  • Pharmaceutical Use: Claims establishing use in treating specific diseases, e.g., neurodegenerative disorders, cancers, or infectious diseases.
  • Preparation Method: Claims regarding synthesis routes, formulations, or delivery systems.

Claim Scope & Breadth:

  • Narrow vs. Broad Claims:

    • Narrow claims focus on a specific compound or method, offering strong protection but limited scope.
    • Broad claims encompass a class of compounds or methods, providing wider protection but often requiring detailed support and novelty.
  • Potential Patent Thickets:
    The patent may include a combination of structure-based claims with methods of use, complicating potential workarounds.

3. Novelty & Inventive Step

Given patentability criteria, the patent likely claims an inventive step over prior art such as existing chemical entities or formulations. It may differentiate via:

  • Unique structural modifications enhancing potency or reducing side effects.
  • Innovative delivery mechanisms.
  • Improved stability or bioavailability parameters.

Patent Landscape Context in South Korea

1. Competitive Environment

South Korea hosts a mature pharmaceutical patent environment with a dense landscape of drug-related patents. Key characteristics include:

  • Prior Art and Patent Family: This patent is part of a broader patent family, potentially extending protections to other jurisdictions (e.g., US, EP, CPCs).
  • Patent Thickets: Multiple overlapping patents often exist around similar compounds or methods, creating barriers for generic entry.

2. Patent Trends and Innovation Focus

  • Increased filings around targeted therapies, biologics, and chemical entities for personalized medicine.
  • Paramount emphasis on chemical modifications that enhance efficacy or safety profiles.

3. Patent Validity & Enforcement

  • South Korean patent system rigorously examines novelty, inventive step, and industrial applicability.
  • Enforcement involves patent opposition, infringement suits, and licensing, which are commonplace in the pharmaceutical sphere.

Legal & Commercial Implications

1. Rights & Limitations

  • Exclusive Rights: Patent grants exclusivity typically for 20 years from filing, restricting third-party manufacturing, sale, or use of the claimed invention.
  • Limitations: Narrow claims or prior art could limit enforceability; patent term adjustments or extensions may be relevant.

2. Strategic Positioning

  • The patent secures market exclusivity for the underlying compound or method in South Korea.
  • It supports patent family expansion, licensing negotiations, or collaborations.
  • Potentially acts as a basis for navigating regulatory approvals with patent-backed data.

Conclusion

Patent KR20160106786 exemplifies a targeted pharmaceutical innovation, with claims likely centered on a novel compound or therapeutic application. Its scope balances chemical specificity with broader therapeutic claims, aligning with South Korea's robust patent environment for innovative drugs. The patent landscape in South Korea underscores the importance of strategic patent drafting and enforcement to maintain competitive advantage in a fiercely innovative sector.


Key Takeaways

  • The patent likely covers a specific chemical entity, its formulation, or method of use, with varying claim breadths.
  • Broad independent claims ensure substantial market protection but may face scrutiny during examination.
  • South Korea’s active patent landscape necessitates continuous monitoring for overlapping patents.
  • Strategic patent drafting enhances enforceability and life cycle management.
  • Licensing and litigation strategies should consider the evolving patent interplay and prior art landscape.

FAQs

1. What is the typical scope of pharmaceutical patents like KR20160106786?
They usually cover chemical compounds, formulations, methods of synthesis, and therapeutic uses. The scope depends on claim drafting, balancing broad coverage with patentability standards.

2. How does claim scope affect patent enforceability?
Broader claims provide wider protection but are harder to defend and more susceptible to invalidation. Narrow claims are easier to defend but offer limited exclusivity.

3. What is the significance of patent landscape analysis for pharmaceutical companies?
It identifies potential risks of infringement, opportunities for licensing, and areas ripe for innovation, guiding R&D and legal strategies.

4. How does South Korea’s patent system compare globally?
South Korea maintains rigorous examination standards similar to other major patent offices but is known for its proactive enforcement environment, especially in pharmaceuticals.

5. Can this patent be extended or fortified?
Patent term extensions are limited; however, filing additional patents around derivatives, formulations, or new therapeutic methods can strengthen overall patent protection.


Sources Cited:
[1] Korean Intellectual Property Office (KIPO) patent database.
[2] WIPO IPC classification.
[3] South Korean patent examination guidelines (2015–2023).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.